Corium Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CORIUM, and when can generic versions of CORIUM drugs launch?
CORIUM has one approved drug.
There are nine US patents protecting CORIUM drugs.
There are eighty-nine patent family members on CORIUM drugs in eleven countries and two supplementary protection certificates in two countries.
Summary for Corium
| International Patents: | 89 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Corium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | 11,648,214 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | 10,300,025 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | 9,993,466 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-001 | Mar 11, 2022 | RX | Yes | No | 10,835,499 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | 11,679,086 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-002 | Mar 11, 2022 | RX | Yes | Yes | 11,103,463 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Corium | ADLARITY | donepezil hydrochloride | SYSTEM;TRANSDERMAL | 212304-001 | Mar 11, 2022 | RX | Yes | No | 9,993,466 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Corium Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20180127315 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2018022815 | ⤷ Sign Up |
| Australia | 2023204240 | ⤷ Sign Up |
| Japan | 7469879 | ⤷ Sign Up |
| Japan | 2022093707 | ⤷ Sign Up |
| Mexico | 2022006681 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2018022814 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Corium Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0296560 | 2/1998 | Austria | ⤷ Sign Up | PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214 |
| 0296560 | SPC/GB97/023 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
